0001683168-24-002286.txt : 20240410 0001683168-24-002286.hdr.sgml : 20240410 20240410215135 ACCESSION NUMBER: 0001683168-24-002286 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240408 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Downs Christopher CENTRAL INDEX KEY: 0001705978 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39126 FILM NUMBER: 24837007 MAIL ADDRESS: STREET 1: 31700 RESEARCH PARK DRIVE CITY: MADISON HEIGHTS STATE: MI ZIP: 48071 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 4 1 ownership.xml X0508 4 2024-04-08 0 0001729427 CNS Pharmaceuticals, Inc. CNSP 0001705978 Downs Christopher C/O CNS PHARMACEUTICALS, INC. 2100 WEST LOOP SOUTH, SUITE 900 HOUSTON TX 77027 0 1 0 0 Chief Financial Officer 0 Option to purchase common stock 0.2586 2024-04-08 4 A 0 40000 A 2034-04-08 Common Stock 40000 201.572 D Restricted Stock Units 2024-04-08 4 A 0 40000 A Common Stock 40000 241.572 D The options set forth in the table vest in 36 equal monthly installments over three years. Issued in connection with the reporting person's employment with the Company. Each restricted stock unit represents a contingent right to receive one share of Company common stock. The restricted stock units set forth in the table vest in eight equal quarterly installments over two years. /s/ Christopher Downs 2024-04-10